A novel treatment for Prader-Willi syndrome, one of the most common genetic causes of obesity, may improve the insatiable hunger that patients with the disorder experience.

"To actually see patients where the research changes the quality of their lives, that’s a huge success."

For several years Vanderbilt University Medical Center researchers have been studying adipose tissue to help unlock the mysteries behind metabolic disorders related to obesity, cardiovascular disease, diabetes and other health conditions, and now they have a new resource to support their investigations.

The new Round Wing location of Vanderbilt University Medical Center’s Elliot V. Newman Clinical Research Center (CRC) opened Dec. 4 with a ribbon-cutting and reception.

David Robertson, MD, internationally known for his groundbreaking work in defining and treating often-debilitating neurological disorders of blood pressure regulation, will be honored with a two-day symposium May 3-4 at Langford Auditorium.

When David Robertson, MD, sorted through 39 years’ worth of textbooks, journals and framed photographs in Vanderbilt University Medical Center’s (VUMC) Clinical Research Center (CRC) recently as he prepared for retirement, the memory that brought him to tears was a 30-year-old embroidery piece by his daughter, Rose Robertson Pink.

Kevin Niswender, MD, PhD, whose work has helped advance understanding of the neural underpinnings of obesity and metabolic syndrome, has been named director of the Clinical Research Center (CRC) at Vanderbilt University Medical Center (VUMC).